This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $290,676 | $324,442 | $250,000 | $282,113 | $279,115 |
| FY2023 | 990 | $389,037 | $366,445 | $300,107 | $316,570 | $312,881 |
| FY2022 | 990 | $405,639 | $370,120 | $300,000 | $290,289 | $290,289 |
| FY2021 | 990 | $457,374 | $394,980 | $300,000 | $254,770 | $254,770 |
| FY2020 | 990 | $440,798 | $704,554 | $600,000 | $192,376 | $192,376 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| RILEY CHILDREN'S FOUNDATIONINDIANAPOLIS, IN | FOR PEDIATRIC CANCER RESEARCH | $600,000 | 2020 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Elizabeth Symmes | President | 40 | $8,333 |
| Joseph Mervis | VP Media | 5 | $0 |
| Brian Holmes | VP Science and Research | 1 | $0 |
| Andrew Thornton | Treasurer |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| For pediatric cancer research |
| $300,107 |
| 2023 |
| Riley Chidren's FoundationIndianapolis, IN | For pediatric cancer research | $300,000 | 2022 |
| RILEY CHILDREN'S FOUNDATIONINDIANAPOLIS, IN | PEDIATRIC CANCER RES | $300,000 | 2021 |
| The Childrens' Oncology Group FoundationPhiladelphia, PA | Contribution to Project Every Child (PEC). PEC is a robust bank of blood and tissue samples from kids with cancer and it is opening the door to groundbreaking advances. | $100,000 | 2024 |
| National Pediatric Cancer FoundationTampa, FL | Funding to support the NPCF's Sunshine Project research initiatives. Over 40 leading children's hospitals across the United States have joined the Sunshine Project Consortium because they believe in a singular mission: to find more effective and less toxic treatments for childhood cancer. The Sunshine Project has a 15-year track record of conducting novel treatment trials for children whose cancers were not curable by standard treatments. NPCF now find themselves at a critical juncture: it is clear that childhood cancer is too complex to expect one new treatment to cure all patients, or even to cure all patients with certain cancer types. To overcome this hurdle, the Sunshine Project has launched a multipronged assault on childhood cancer from many angles. | $100,000 | 2024 |
| Indiana University FoundationIndianapolis, IN | Donation by the Teen Board used in Dr Vik's Ampath lab. Ampath Kenya is a partnership between Moi University, Moi Teaching and Referral Hospital, the AMPATH Consortium of universities around the world led by Indiana University, and the Kenyan Government. Together, they work to build holistic, sustainable health in Kenya and around the world. | $25,000 | 2024 |
| Oncoheros Biosciences IncHolliston, MA | To fund research developing Volasertib, a drug for children and adolescents with cancer. | $25,000 | 2024 |
| 1 |
| $0 |
| Ryan Drook | Board member | 1 | $0 |
| Emily Czarnecki | Board Member | 1 | $0 |
| David Symmes | Board Member | 1 | $0 |
| Jason Cosgrove | Board Member | 1 | $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2024 · period ending Dec 31, 2024IRS bulk XML
Filing id 202523009349301802
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202412159349301666
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202322089349301507
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202241369349301849
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202103169349302440
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201941689349300764
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201811289349301246
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201741589349300549
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.